Background The effect of direct oral anticoagulants (DOACs) on evolution of a post-
thrombotic syndrome (PTS) is unknown. Methods and results This retrospective study …

The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis
(DVT) treated with direct oral anticoagulants (DOACs) remains a matter of debate. Hence …

Background: Anticoagulation for venous thromboembolism (VTE) is required for at least
three to six months; however, it is advisable to extend the duration in certain cases, in which …

The novel direct oral anticoagulants (DOAC) have been shown to be at least as effective as
and safer than conventional anticoagulants for the initial and long-term treatment of venous …

Introduction Post-thrombotic syndrome (PTS) is a chronic complication of deep vein
thrombosis (DVT) that affects 20% to 50% of DVT patients. Standard DVT treatment included …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

Background Postthrombotic syndrome (PTS) is a long‐term complication after deep vein
thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood …

BACKGROUND: Little is known about medication adherence patterns and their association
with effectiveness and safety among patients with venous thromboembolism (VTE) receiving …

Background: Risk factors for post‐thrombotic syndrome (PTS) remain poorly understood.
Objectives: In this multinational multicenter study, we evaluated whether subtherapeutic …

Essentials• Post thrombotic syndrome (PTS) is a complication of deep vein thrombosis (DVT)
with limited treatment options.• Uniformity of the diagnostic strategy and the use of risk …